The Transformative Potential of Left Ventricular Assist Devices in Advanced Heart Failure: No More a Therapeutic Orphan

Overview

Journal Eur Heart J

Publisher Oxford University Press

Specialty Cardiology & Vascular Diseases

Date 2023 Dec 11

PMID 38073194

Authors

Mandeep R Mehra

Francesco Castagna

Javed Butler

Affiliations

Soon will be listed here.

Citing Articles

Outcome Through the Years of Left-Ventricular Assist Devices Therapy for End-Stage Heart Failure: A Review.

Tropea I, Cresce G, Sanesi V, Salvador L, Zoni D J Clin Med. 2024; 13(21).

PMID: 39518766 PMC: 11546408. DOI: 10.3390/jcm13216622.

Are mechanical circulatory supports the forgotten aspect in the implementation of therapies for heart failure?.

Baudry G, Metra M, Delmas C Eur J Heart Fail. 2024; 26(11):2392-2395.

PMID: 39148316 PMC: 11659489. DOI: 10.1002/ejhf.3422.

References

Mezzacappa C, Ravindra N, Caraballo C, Chouairi F, Miller P, Clarke J . Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure. PLoS One. 2020; 15(12):e0242928. PMC: 7714148. DOI: 10.1371/journal.pone.0242928. View

Mehra M . The burden of haemocompatibility with left ventricular assist systems: a complex weave. Eur Heart J. 2017; 40(8):673-677. DOI: 10.1093/eurheartj/ehx036. View

Boulet J, Nayak A, Mehra M . Hemodynamic Aberrancies in Left Ventricular Assist Device-Associated Heart Failure Syndromes. J Card Fail. 2022; 28(12):1738-1740. DOI: 10.1016/j.cardfail.2022.09.007. View

Patel C, Blue L, Cagliostro B, Bailey S, Entwistle J, John R . Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial. J Heart Lung Transplant. 2020; 39(8):774-781. DOI: 10.1016/j.healun.2020.03.002. View

Mehra M, Uriel N, Naka Y, Cleveland Jr J, Yuzefpolskaya M, Salerno C . A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019; 380(17):1618-1627. DOI: 10.1056/NEJMoa1900486. View

Mehra M, Nayak A, Morris A, Lanfear D, Nemeh H, Desai S . Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device. JACC Heart Fail. 2022; 10(12):948-959. DOI: 10.1016/j.jchf.2022.08.002. View

Schmitto J, Shaw S, Garbade J, Gustafsson F, Morshuis M, Zimpfer D . Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry. Eur Heart J. 2023; 45(8):613-625. PMC: 10959573. DOI: 10.1093/eurheartj/ehad658. View

Mehra M, Goldstein D, Cleveland J, Cowger J, Hall S, Salerno C . Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022; 328(12):1233-1242. PMC: 9459909. DOI: 10.1001/jama.2022.16197. View

Boulet J, Wanderley Jr M, Mehra M . Contemporary Left Ventricular Assist Device Therapy as a Bridge or Alternative to Transplantation. Transplantation. 2023; 108(6):1333-1341. DOI: 10.1097/TP.0000000000004834. View

10.

Crespo-Leiro M, Metra M, Lund L, Milicic D, Costanzo M, Filippatos G . Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018; 20(11):1505-1535. DOI: 10.1002/ejhf.1236. View

11.

Netuka I, Sood P, Pya Y, Zimpfer D, Krabatsch T, Garbade J . Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study. J Am Coll Cardiol. 2015; 66(23):2579-2589. DOI: 10.1016/j.jacc.2015.09.083. View

12.

Goldstein D, Naka Y, Horstmanshof D, Ravichandran A, Schroder J, Ransom J . Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3.... JAMA Cardiol. 2020; 5(4):411-419. PMC: 6990746. DOI: 10.1001/jamacardio.2019.5323. View

13.

Mehra M, Gustafsson F . Left Ventricular Assist Devices at the Crossroad of Innovation in Advanced Heart Failure. J Card Fail. 2021; 27(11):1291-1294. DOI: 10.1016/j.cardfail.2021.06.003. View

14.

Mehra M, Nayak A, Desai A . Life-Prolonging Benefits of LVAD Therapy in Advanced Heart Failure: A Clinician's Action and Communication Aid. JACC Heart Fail. 2023; 11(8 Pt 1):1011-1017. DOI: 10.1016/j.jchf.2023.05.013. View

15.

Lim H, Shaw S, Carter A, Jayawardana S, Mossialos E, Mehra M . A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective. J Heart Lung Transplant. 2021; 41(2):174-186. DOI: 10.1016/j.healun.2021.11.014. View